Ruth Etzioni

27.6k total citations · 14 hit papers
248 papers, 18.3k citations indexed

About

Ruth Etzioni is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Statistics and Probability. According to data from OpenAlex, Ruth Etzioni has authored 248 papers receiving a total of 18.3k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Pulmonary and Respiratory Medicine, 122 papers in Oncology and 39 papers in Statistics and Probability. Recurrent topics in Ruth Etzioni's work include Prostate Cancer Diagnosis and Treatment (101 papers), Prostate Cancer Treatment and Research (91 papers) and Global Cancer Incidence and Screening (79 papers). Ruth Etzioni is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (101 papers), Prostate Cancer Treatment and Research (91 papers) and Global Cancer Incidence and Screening (79 papers). Ruth Etzioni collaborates with scholars based in United States, South Africa and Netherlands. Ruth Etzioni's co-authors include Roman Gulati, Eric J. Feuer, Scott D. Ramsey, David F. Penson, Angela B. Mariotto, Robert A. Smith, Richard C. Wender, Nicole Urban, Kimberly Andrews and Ya‐Chen Tina Shih and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Ruth Etzioni

239 papers receiving 17.8k citations

Hit Papers

Colorectal cancer screenin... 2001 2026 2009 2017 2018 2001 2015 2003 2013 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society
    2018 1.3k citations Andrew M. D. Wolf, Elizabeth T. H. Fontham et al. CA A Cancer Journal for Clinicians profile →
  2. Phases of Biomarker Development for Early Detection of Cancer
    2001 1.2k citations Ruth Etzioni et al. JNCI Journal of the National Cancer Institute profile →
  3. Breast Cancer Screening for Women at Average Risk
    2015 1.2k citations Kevin C. Oeffinger, Elizabeth T. H. Fontham et al. profile →
  4. The case for early detection
    2003 902 citations Ruth Etzioni, Stephen M. Schwartz et al. profile →
  5. Early Detection of Prostate Cancer: AUA Guideline
    2013 872 citations Ruth Etzioni, David F. Penson et al. profile →
  6. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
    2010 736 citations Richard C. Wender, Ruth Etzioni et al. CA A Cancer Journal for Clinicians profile →
  7. Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends
    2002 685 citations Ruth Etzioni JNCI Journal of the National Cancer Institute profile →
  8. Overdiagnosis and Overtreatment of Prostate Cancer
    2014 680 citations David F. Penson, Peter R. Carroll et al. profile →
  9. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
    2020 606 citations Elizabeth T. H. Fontham, Andrew M. D. Wolf et al. CA A Cancer Journal for Clinicians profile →
  10. Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
    2009 578 citations Gerrit Draisma, Ruth Etzioni et al. JNCI Journal of the National Cancer Institute profile →
  11. American Cancer Society lung cancer screening guidelines
    2013 561 citations Richard C. Wender, Elizabeth T. H. Fontham et al. CA A Cancer Journal for Clinicians profile →
  12. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States
    2017 381 citations Angela B. Mariotto, Ruth Etzioni et al. Cancer Epidemiology Biomarkers & Prevention profile →
  13. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening
    2023 172 citations John T. Wei, Ruth Etzioni et al. profile →
  14. Screening for lung cancer: 2023 guideline update from the American Cancer Society
    2023 134 citations Andrew M. D. Wolf, Kevin C. Oeffinger et al. CA A Cancer Journal for Clinicians profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Etzioni United States 58 7.9k 7.8k 2.8k 2.3k 2.2k 248 18.3k
Neal J. Meropol United States 61 13.1k 1.7× 5.2k 0.7× 3.1k 1.1× 2.5k 1.1× 3.5k 1.6× 307 19.4k
Kathleen A. Cronin United States 50 9.6k 1.2× 3.9k 0.5× 2.6k 1.0× 1.7k 0.7× 3.9k 1.8× 118 17.5k
Nadia Howlader United States 28 8.5k 1.1× 4.5k 0.6× 3.1k 1.1× 2.1k 0.9× 3.2k 1.5× 52 17.4k
John J. Crowley United States 59 8.0k 1.0× 8.8k 1.1× 3.9k 1.4× 2.0k 0.9× 1.8k 0.8× 195 17.8k
Gregory R. Pond Canada 65 5.7k 0.7× 5.6k 0.7× 2.6k 0.9× 3.3k 1.4× 1.9k 0.9× 575 15.8k
Paul L. Nguyen United States 62 4.8k 0.6× 9.6k 1.2× 1.7k 0.6× 2.8k 1.2× 2.5k 1.1× 558 16.6k
Mahesh Parmar United Kingdom 71 8.3k 1.1× 11.0k 1.4× 2.3k 0.8× 6.7k 2.9× 2.4k 1.1× 299 27.0k
Christoph Zielinski Austria 69 10.1k 1.3× 5.7k 0.7× 5.0k 1.8× 1.7k 0.7× 2.6k 1.2× 499 20.8k
Eitan Amir Canada 57 8.8k 1.1× 3.9k 0.5× 2.6k 0.9× 2.0k 0.9× 3.6k 1.6× 416 15.4k
Betsy Kohler United States 30 6.2k 0.8× 2.9k 0.4× 2.6k 1.0× 1.9k 0.8× 2.0k 0.9× 61 13.9k

Countries citing papers authored by Ruth Etzioni

Since Specialization
Citations

This map shows the geographic impact of Ruth Etzioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Etzioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Etzioni more than expected).

Fields of papers citing papers by Ruth Etzioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Etzioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Etzioni. The network helps show where Ruth Etzioni may publish in the future.

Co-authorship network of co-authors of Ruth Etzioni

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Etzioni. A scholar is included among the top collaborators of Ruth Etzioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Etzioni. Ruth Etzioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gulati, Roman, Jane Lange, Antonio Olivas‐Martínez, et al.. (2025). Sensitivity Measures in Studies of Cancer Early Detection Biomarkers. Cancer Epidemiology Biomarkers & Prevention. 34(6). 944–951.
2.
Rebolj, Matejka, Adam R. Brentnall, Julia Geppert, et al.. (2025). Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis. Cancer Epidemiology Biomarkers & Prevention. 34(10). 1694–1709. 1 indexed citations
3.
Ji, Mengmeng, John H. Huber, Mei Wang, et al.. (2024). Asymptomatic Incidence of Monoclonal Gammopathy of Undetermined Significance and Preclinical Duration to Myeloma Diagnosis: A Modeling Study. Cancer Epidemiology Biomarkers & Prevention. 33(12). 1690–1697. 2 indexed citations
4.
Lange, Jane, et al.. (2024). Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling. Cancer Epidemiology Biomarkers & Prevention. 33(6). 830–837. 8 indexed citations
5.
Holt, Sarah K., Anirban Basu, Ruth Etzioni, et al.. (2024). Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment. Cancer Epidemiology Biomarkers & Prevention. 33(3). 435–441. 2 indexed citations
6.
Lange, Jane, Charlotte C. Gard, Ellen S. O’Meara, Diana L. Miglioretti, & Ruth Etzioni. (2024). Breast density and risk of breast cancer: masking and detection bias. American Journal of Epidemiology. 194(2). 441–448.
7.
Holt, Sarah K., Ruth Etzioni, Jenney R. Lee, et al.. (2024). The association of where patients with prostate cancer live and receive care on racial treatment inequities. JNCI Journal of the National Cancer Institute. 117(4). 713–718.
8.
García‐Albéniz, Xabier, John Hsu, Ruth Etzioni, et al.. (2024). Prostate-Specific Antigen Screening and Prostate Cancer Mortality: An Emulation of Target Trials in US Medicare. JCO Clinical Cancer Informatics. 8(8). e2400094–e2400094. 1 indexed citations
9.
Devasia, Theresa P., Angela B. Mariotto, Yaw A. Nyame, & Ruth Etzioni. (2023). Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States. Cancer Epidemiology Biomarkers & Prevention. 32(5). 659–665. 16 indexed citations
10.
Nyame, Yaw A., Sarah K. Holt, Ruth Etzioni, & John L. Gore. (2023). Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer. Cancer. 129(9). 1402–1410. 6 indexed citations
11.
Menon, Usha, et al.. (2023). Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?. Cancer Epidemiology Biomarkers & Prevention. 32(6). 741–743. 3 indexed citations
12.
Chitsazan, Alex, et al.. (2022). Spatial Prediction of COVID-19 Pandemic Dynamics in the United States. ISPRS International Journal of Geo-Information. 11(9). 470–470. 2 indexed citations
13.
Jiao, Boshen, Roman Gulati, Hormuzd A. Katki, Philip E. Castle, & Ruth Etzioni. (2021). A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing. Cancer Epidemiology Biomarkers & Prevention. 31(1). 38–44. 13 indexed citations
14.
Fontham, Elizabeth T. H., Andrew M. D. Wolf, Timothy R. Church, et al.. (2020). Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA A Cancer Journal for Clinicians. 70(5). 321–346. 606 indexed citations breakdown →
15.
Beatty, J. David, Catherine R. Fedorenko, Jane Lange, et al.. (2020). Incorporating Breast Cancer Recurrence Events Into Population-Based Cancer Registries Using Medical Claims: Cohort Study. JMIR Cancer. 6(2). e18143–e18143. 8 indexed citations
16.
Ryser, Marc D., Roman Gulati, Marisa C. Eisenberg, et al.. (2018). Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening Trials. American Journal of Epidemiology. 188(1). 197–205. 12 indexed citations
17.
Feng, Ziding, Roman Gulati, Jing Fan, et al.. (2015). Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 24(4). 677–682. 15 indexed citations
18.
Xia, Jing, Bruce J. Trock, Roman Gulati, et al.. (2014). Overdetection of Recurrence after Radical Prostatectomy: Estimates Based on Patient and Tumor Characteristics. Clinical Cancer Research. 20(20). 5302–5310. 13 indexed citations
19.
Gulati, Roman, Elisabeth M. Wever, Alex Tsodikov, et al.. (2011). What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models. Cancer Epidemiology Biomarkers & Prevention. 20(5). 740–750. 34 indexed citations
20.
Fedewa, Stacey A., Ruth Etzioni, W. Dana Flanders, Ahmedin Jemal, & Elizabeth Ward. (2010). Association of Insurance and Race/Ethnicity with Disease Severity among Men Diagnosed with Prostate Cancer, National Cancer Database 2004-2006. Cancer Epidemiology Biomarkers & Prevention. 19(10). 2437–2444. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neal J. Meropol Breakdown of academic impact, for papers by Kathleen A. Cronin Breakdown of academic impact, for papers by Nadia Howlader Breakdown of academic impact, for papers by John J. Crowley Breakdown of academic impact, for papers by Gregory R. Pond Breakdown of academic impact, for papers by Paul L. Nguyen Breakdown of academic impact, for papers by Mahesh Parmar Breakdown of academic impact, for papers by Christoph Zielinski Breakdown of academic impact, for papers by Eitan Amir Breakdown of academic impact, for papers by Betsy Kohler
Rankless by CCL
2026